Interim results of the JULIET trial of CTL019 in R/R DLBCL
EBMT 2019 | A consensus grading system for toxicities in CAR T trials
A new grading system for use in chimeric antigen receptor (CAR) T-cell trials was presented on Tuesday 26 March 2019, during the 45th Meeting of the EBMT
CAR T Cell Meeting 2019 | CAR T-cell therapy in lymphoma
A talk was presented by Marie José Kersten, Department of Haematology, Academic Medical Center, Amsterdam, Netherlands, on when to use CAR t in lymphoma.
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month